These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 20718497)

  • 1. Inhibition of mycobacterial replication by pyrimidines possessing various C-5 functionalities and related 2'-deoxynucleoside analogues using in vitro and in vivo models.
    Srivastav NC; Rai D; Tse C; Agrawal B; Kunimoto DY; Kumar R
    J Med Chem; 2010 Aug; 53(16):6180-7. PubMed ID: 20718497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of novel 5-(ethyl or hydroxymethyl) analogs of 2'-'up' fluoro (or hydroxyl) pyrimidine nucleosides as a new class of Mycobacterium tuberculosis, Mycobacterium bovis and Mycobacterium avium inhibitors.
    Shakya N; Srivastav NC; Bhavanam S; Tse C; Desroches N; Agrawal B; Kunimoto DY; Kumar R
    Bioorg Med Chem; 2012 Jul; 20(13):4088-97. PubMed ID: 22664188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis and antimycobacterial activity of some novel imidazo[1,2-c]pyrimidines.
    Chhabria MT; Jani MH
    Eur J Med Chem; 2009 Oct; 44(10):3837-44. PubMed ID: 19423196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of Mycobacterium tuberculosis, Mycobacterium bovis, and Mycobacterium avium by novel dideoxy nucleosides.
    Rai D; Johar M; Srivastav NC; Manning T; Agrawal B; Kunimoto DY; Kumar R
    J Med Chem; 2007 Sep; 50(19):4766-74. PubMed ID: 17696514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth inhibition of Mycobacterium bovis, Mycobacterium tuberculosis and Mycobacterium avium in vitro: effect of 1-beta-D-2'-arabinofuranosyl and 1-(2'-deoxy-2'-fluoro-beta-D-2'-ribofuranosyl) pyrimidine nucleoside analogs.
    Johar M; Manning T; Tse C; Desroches N; Agrawal B; Kunimoto DY; Kumar R
    J Med Chem; 2007 Jul; 50(15):3696-705. PubMed ID: 17602465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3'-bromo analogues of pyrimidine nucleosides as a new class of potent inhibitors of Mycobacterium tuberculosis.
    Shakya N; Srivastav NC; Desroches N; Agrawal B; Kunimoto DY; Kumar R
    J Med Chem; 2010 May; 53(10):4130-40. PubMed ID: 20420370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thienopyrimidines as novel inhibitors of Mycobacterium tuberculosis: synthesis and in-vitro studies.
    Rashmi P; Nargund LV; Hazra K; Chandra JN
    Arch Pharm (Weinheim); 2011 Jul; 344(7):459-65. PubMed ID: 21598298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The synthesis and antituberculosis activity of 5-alkynyl uracil derivatives.
    Platonova YB; Volov AN; Tomilova LG
    Bioorg Med Chem Lett; 2020 Aug; 30(16):127351. PubMed ID: 32631549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substituted benzyl-pyrimidines targeting thymidine monophosphate kinase of Mycobacterium tuberculosis: synthesis and in vitro anti-mycobacterial activity.
    Gasse C; Douguet D; Huteau V; Marchal G; Munier-Lehmann H; Pochet S
    Bioorg Med Chem; 2008 Jun; 16(11):6075-85. PubMed ID: 18467107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel dihydropyrimidines as a potential new class of antitubercular agents.
    Trivedi AR; Bhuva VR; Dholariya BH; Dodiya DK; Kataria VB; Shah VH
    Bioorg Med Chem Lett; 2010 Oct; 20(20):6100-2. PubMed ID: 20813528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation and in-vitro evaluation of 4-benzylsulfanylpyridine-2-carbohydrazides as potential antituberculosis agents.
    Herzigová P; Klimesová V; Palát K; Kaustová J; Dahse HM; Möllmann U
    Arch Pharm (Weinheim); 2009 Jul; 342(7):394-404. PubMed ID: 19536781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and antituberculosis activity of a novel series of optically active 6-nitro-2,3-dihydroimidazo[2,1-b]oxazoles.
    Sasaki H; Haraguchi Y; Itotani M; Kuroda H; Hashizume H; Tomishige T; Kawasaki M; Matsumoto M; Komatsu M; Tsubouchi H
    J Med Chem; 2006 Dec; 49(26):7854-60. PubMed ID: 17181168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A small library of trisubstituted pyrimidines as antimalarial and antitubercular agents.
    Agarwal A; Srivastava K; Puri SK; Sinha S; Chauhan PM
    Bioorg Med Chem Lett; 2005 Dec; 15(23):5218-21. PubMed ID: 16171994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and in vitro evaluation of substituted pyrimido[5,4-d]pyrimidines as a novel class of anti-Mycobacterium tuberculosis agents.
    Bacelar AH; Carvalho MA; Proença MF
    Eur J Med Chem; 2010 Jul; 45(7):3234-9. PubMed ID: 20416983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Facile transformation of Biginelli pyrimidin-2(1H)-ones to pyrimidines. In vitro evaluation as inhibitors of Mycobacterium tuberculosis and modulators of cytostatic activity.
    Singh K; Singh K; Wan B; Franzblau S; Chibale K; Balzarini J
    Eur J Med Chem; 2011 Jun; 46(6):2290-4. PubMed ID: 21450375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of capuramycin analogues against Mycobacterium tuberculosis, Mycobacterium avium and Mycobacterium intracellulare in vitro and in vivo.
    Koga T; Fukuoka T; Doi N; Harasaki T; Inoue H; Hotoda H; Kakuta M; Muramatsu Y; Yamamura N; Hoshi M; Hirota T
    J Antimicrob Chemother; 2004 Oct; 54(4):755-60. PubMed ID: 15347635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Facile one-pot synthesis and antimycobacterial evaluation of pyrazolo[3,4-d]pyrimidines.
    Trivedi A; Dodiya D; Surani J; Jarsania S; Mathukiya H; Ravat N; Shah V
    Arch Pharm (Weinheim); 2008 Jul; 341(7):435-9. PubMed ID: 18574851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-tubercular agents. Part 3. Benzothiadiazine as a novel scaffold for anti-Mycobacterium activity.
    Kamal A; Reddy KS; Ahmed SK; Khan MN; Sinha RK; Yadav JS; Arora SK
    Bioorg Med Chem; 2006 Feb; 14(3):650-8. PubMed ID: 16203154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluorinated 1,2,4-Triazolo[1,5-a]pyrimidine-6-carboxylic acid derivatives as antimycobacterial agents.
    Abdel-Rahman HM; El-Koussi NA; Hassan HY
    Arch Pharm (Weinheim); 2009 Feb; 342(2):94-9. PubMed ID: 19173243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.